Gene Therapy - Table of Contents alert Volume 25 Issue 6

If you are unable to see the message below, click here to view.

Advertisement GMP AAV: A Helping Hand for Gene Therapy Production  With a little help(er), gene therapy companies continue to innovate.  Learn how companies are using helper virus to boost AAV production.   TABLE OF CONTENTS Volume 25, Issue 6 In this issue Comment Article Brief Communication Correction Also new AOP   Comment Diabetic complication could get a gene therapy boost Julio Enrique Castañeda-Delgado Gene Therapy 2018 25 :401 - 401; August 10, 2018; 10.1038/s41434-018-0037-4   Abstract | Full Text Article Serotype survey of AAV gene delivery via subconjunctival injection in mice Liujiang Song, Telmo Llanga, Laura M. Conatser, Violeta Zaric, Brian C. Gilger et al. Gene Therapy 2018 25 :402 - 414; August 02, 2018; 10.1038/s41434-018-0035-6   Abstract | Full Text Optimization of viral protein ratios for production of rAAV serotype 5 in the baculovirus system Bas Bosma, Francois du Plessis, Erich Ehlert, Bart Nijmeijer, Martin de Haan et al. Gene Therapy 2018 25 :415 - 424; August 01, 2018; 10.1038/s41434-018-0034-7   Abstract | Full Text Brief Communication Nanosphere-mediated co-delivery of VEGF-A and PDGF-B genes for accelerating diabetic foot ulcers healing in rats Rongfeng Shi, Weishuai Lian, Shilong Han, Chuanwu Cao, Yinpeng Jin et al. Gene Therapy 2018 25 :425 - 438; June 28, 2018; 10.1038/s41434-018-0027-6   Abstract | Full Text Additive effects of the combined expression of soluble forms of GAS1 and PTEN inhibiting glioblastoma growth Laura Sánchez-Hernández, Justino Hernández-Soto, Paula Vergara, Rosa O. González & José Segovia Gene Therapy 2018 25 :439 - 449; June 25, 2018; 10.1038/s41434-018-0020-0   Abstract | Full Text Correction Correction: Development of an optimized AAV2/5 gene therapy vector for Leber congenital amaurosis owing to defects in RPE65 A. Georgiadis, Y. Duran, J. Ribeiro, L. Abelleira-Hervas, S. J. Robbie et al. Gene Therapy 2018 25 :450 - 450; July 25, 2018; 10.1038/s41434-018-0031-x   Abstract | Full Text Advertisement Nature Briefing is an essential round-up of science news, opinion and analysis, free in your inbox every weekday. With Nature Briefing, we'll keep you updated on the latest research, so you can focus on yours. Click here to sign up. Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Gene Therapy. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Springer Nature's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. Nature is part of Springer Nature. © 2018 Springer Nature Limited. All rights reserved.